The effect of curcumin supplementation on Nonalcoholic Fatty Liver Disease

Not Applicable

• Conditions: onalcoholic Fatty Liver Disease.; Other specified inflammatory liver diseases; (K75.8)

• Registration Number: IRCT20100524004010N24
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 June 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Age >18 years old
Controlled Attenuation Parameter (CAP score)>263
Having a history of alcohol consumption less than 10 mg per day in women and less than 20 mg per day in men
Absence of other acute and chronic diseases and disorders of the liver (hepatitis B, C, etc.), biliary disease, known autoimmune diseases, cancer and inherited disorders affecting liver condition (storage disease of iron, and copper. ..)
Absence of Hypertension, cardio - vascular diseases, lung disease and kidney disease, cirrhosis and celiac disease
Absence of pregnancy or lactation
Athletes or hospitalization
Not consume medications such as metformin, vitamin E and Ursodeoxycholic Acid (UDCA)
Not consume hepatotoxic drugs such as phenytoin, tamoxifen and lithium and corticosteroids and methotrexate
Not consume medications of antibiotics over a week during the study period or before entering it
No history of weight loss surgery in the past year the 3-month weight loss program
No history of hypothyroidism, Cushing's syndrome and diabetes
Lack of gall bladder disease

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified